298 related articles for article (PubMed ID: 22429778)
1. Expression of 12 cytokines in aqueous humour of uveal melanoma before and after combined Ruthenium-106 brachytherapy and transpupillary thermotherapy.
Lee CS; Jun IH; Kim TI; Byeon SH; Koh HJ; Lee SC
Acta Ophthalmol; 2012 Jun; 90(4):e314-20. PubMed ID: 22429778
[TBL] [Abstract][Full Text] [Related]
2. Intraocular activation of angiogenic and inflammatory pathways in uveal melanoma.
Dunavoelgyi R; Funk M; Sacu S; Georgopoulos M; Zlabinger G; Zehetmayer M; Schmidt-Erfurth U
Retina; 2012 Jul; 32(7):1373-84. PubMed ID: 22418780
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor a in eyes with uveal melanoma.
Missotten GS; Notting IC; Schlingemann RO; Zijlmans HJ; Lau C; Eilers PH; Keunen JE; Jager MJ
Arch Ophthalmol; 2006 Oct; 124(10):1428-34. PubMed ID: 17030710
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraocular surgery and ketamine on aqueous and serum cytokines.
Tu KL; Kaye SB; Sidaras G; Taylor W; Shenkin A
Mol Vis; 2007 Jul; 13():1130-7. PubMed ID: 17653058
[TBL] [Abstract][Full Text] [Related]
5. Regression of uveal melanoma after ru-106 brachytherapy and thermotherapy based on metabolic activity measured by positron emission tomography/computed tomography.
Lee CS; Lee SC; Lee K; Kwon HJ; Yi JH; Cho A
Retina; 2014 Jan; 34(1):182-7. PubMed ID: 23719400
[TBL] [Abstract][Full Text] [Related]
6. [Prospective nonrandomised analysis of "Sandwich Therapy" for malignant melanoma of the choroid].
Stoffelns BM; Kutzner J; Schöpfer K; Frising M
Klin Monbl Augenheilkd; 2002 Apr; 219(4):211-5. PubMed ID: 12022003
[TBL] [Abstract][Full Text] [Related]
7. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone.
Yarovoy AA; Magaramov DA; Bulgakova ES
Brachytherapy; 2012; 11(3):224-9. PubMed ID: 22104351
[TBL] [Abstract][Full Text] [Related]
8. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.
Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S
Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.
Nagarkatti-Gude N; Bronkhorst IH; van Duinen SG; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6748-55. PubMed ID: 22930720
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium-106 plaque brachytherapy for uveal melanoma.
Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
12. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
[TBL] [Abstract][Full Text] [Related]
14. [Tumor regression in malignant choroidal melanomas after transpupillary thermotherapy (TTT) versus ruthenium brachytherapy and sandwich therapy - a comparative analysis].
Stoffelns BM; Schoepfer K; Jochem T; Faldum A
Klin Monbl Augenheilkd; 2010 Apr; 227(4):262-8. PubMed ID: 20408070
[TBL] [Abstract][Full Text] [Related]
15. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients.
Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Dendale R; Delacroix S; Nauraye C; Estève M; Plancher C; Asselain B
Ophthalmic Res; 2006; 38(5):255-60. PubMed ID: 16888407
[TBL] [Abstract][Full Text] [Related]
16. [Transpupillary thermotherapy of choroidal melanoma].
Schneider H; Fischer K; Fietkau R; Guthoff RF
Klin Monbl Augenheilkd; 1999 Feb; 214(2):90-5. PubMed ID: 10218201
[TBL] [Abstract][Full Text] [Related]
17. [Transpupillary thermotherapy combined with 106Ru as a method of managing choroidal melanoma].
Starzycka M; Romanowska-Dixon B; Słomska J; Szpakowicz U
Klin Oczna; 2000; 102(4):249-52. PubMed ID: 11291294
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
19. Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
Usui Y; Tsubota K; Agawa T; Ueda S; Umazume K; Okunuki Y; Kezuka T; Yamakawa N; Goto H
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):393-399. PubMed ID: 27878431
[TBL] [Abstract][Full Text] [Related]
20. Early macular morphological changes following plaque radiotherapy for uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA
Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
